Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Radiotherapy and re-irradiation of breast cancer patients with brain metastases: Survival in the trastuzumab era].

Literature DB >> 22638937

[Radiotherapy and re-irradiation of breast cancer patients with brain metastases: Survival in the trastuzumab era].

C Nieder¹.

Abstract

Entities: Chemical Disease Species

Year: 2012 PMID： 22638937 DOI： 10.1007/s00066-012-0135-y

Source DB: PubMed Journal: Strahlenther Onkol ISSN： 0179-7158 Impact factor: 3.621

Keyword Cloud
References

× No keyword cloud information.

7 in total

1. Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine.

Authors: G Metro; J Foglietta; M Russillo; L Stocchi; A Vidiri; D Giannarelli; L Crinò; P Papaldo; M Mottolese; F Cognetti; A Fabi; S Gori
Journal: Ann Oncol Date: 2010-08-19 Impact factor: 32.976

2. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.

Authors: Paul W Sperduto; Norbert Kased; David Roberge; Zhiyuan Xu; Ryan Shanley; Xianghua Luo; Penny K Sneed; Samuel T Chao; Robert J Weil; John Suh; Amit Bhatt; Ashley W Jensen; Paul D Brown; Helen A Shih; John Kirkpatrick; Laurie E Gaspar; John B Fiveash; Veronica Chiang; Jonathan P S Knisely; Christina Maria Sperduto; Nancy Lin; Minesh Mehta
Journal: Int J Radiat Oncol Biol Phys Date: 2011-04-15 Impact factor: 7.038

3. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.

Authors: E Shaw; C Scott; L Souhami; R Dinapoli; R Kline; J Loeffler; N Farnan
Journal: Int J Radiat Oncol Biol Phys Date: 2000-05-01 Impact factor: 7.038

4. Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis.

Authors: Giuseppe Roberto D'Agostino; Rosa Autorino; Angelo Pompucci; Maria Carmen De Santis; Stefania Manfrida; Giuseppe Di Lella; Giovanna Mantini; Vincenzo Frascino; Silvia Chiesa; Alessio Albanese; Nicola Dinapoli; Luigi Azario; Alba Fiorentino; Vincenzo Valentini; Carmelo Anile; Mario Balducci
Journal: Strahlenther Onkol Date: 2011-06-28 Impact factor: 3.621

[Radiotherapy and re-irradiation of breast cancer patients with brain metastases: Survival in the trastuzumab era].

1. Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine.

2. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.

3. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.

4. Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis.

5. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases.

6. Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases.

7. Prognostic scores in brain metastases from breast cancer.